---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-037147"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2022-12-30T23:59:59+00:00"
generated_at: "2026-06-20T21:29:45.416545+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PAVmed receives Nasdaq deficiency notice for bid price below $1 per share

## Summary
- On Dec 29, 2022, Nasdaq notified PAVmed that its common stock bid price closed below $1 for 30 consecutive business days.
- Company has 180 calendar days, until June 27, 2023, to regain compliance by having stock close at $1 for 10 consecutive days.
- If not compliant by June 27, 2023, PAVmed may be eligible for an additional 180-day period to cure the deficiency.
- Nasdaq notice does not currently affect listing of PAVM common stock or PAVMZ warrants; they continue trading.
- Company intends to consider all available options to regain compliance with Nasdaq listing standards.

## SEC filing metadata
- accession: 0001493152-22-037147
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2022-12-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315222037147/0001493152-22-037147-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315222037147/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-037147
- JSON: https://secwatch.observer/filing/0001493152-22-037147.json
- Plain text: https://secwatch.observer/filing/0001493152-22-037147.txt

## Key facts
- Listing & Compliance Notices
  PAVmed Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: December 29, 2022, PAVmed Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that, for the prior 30 consecutive business days (through December 28, 2022), the closing bid price of the Company’s common stock had been below the minimum of $1 per share required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The notification letter stated that the Company would be afforded 180 calendar days (until June 27, 2023) to regain compliance. In order to regain compliance, the clos
  evidence_url: https://www.sec.gov/Archives/edgar/data/1624326/000149315222037147/0001493152-22-037147-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.